12/10
08:08 am
rvnc
Rating for RVNC
Low
Report
Rating for RVNC
12/10
08:08 am
rvnc
Rating for RVNC
Low
Report
Rating for RVNC
11/8
01:44 pm
rvnc
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
11/8
01:22 pm
rvnc
Rating for RVNC
Medium
Report
Rating for RVNC
11/8
01:22 pm
rvnc
Rating for RVNC
Medium
Report
Rating for RVNC
11/8
11:37 am
rvnc
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $6.60 price target on the stock.
Low
Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $6.60 price target on the stock.
10/28
01:16 pm
rvnc
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
10/28
01:10 pm
rvnc
Rating for RVNC
Report
Rating for RVNC
10/28
01:10 pm
rvnc
Rating for RVNC
Report
Rating for RVNC